We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Ludka Zimovcak has been assisting clients through the H1B Visa process since 2020.

As of 2022, Ludka Zimovcak has succesfully submitted and recieved certification for 492 cases.

Ludka Zimovcak is located in Ridgewood, NJ, and has represented 93 employers for the H1B Visa Process

516
Cases Handled
492
Cases Certified
95.35%
Approval

Cases Handled by Ludka Zimovcak

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-22327-604933 Withdrawn Chemists Medicinal And Botanical Manufacturing Endo Pharmaceuticals Inc 2023
I-200-22139-190476 Certified Chemists Medicinal And Botanical Manufacturing Endo Pharmaceuticals Inc 2022
I-200-22132-164545 Certified Chemists Medicinal And Botanical Manufacturing Endo Pharmaceuticals Inc 2022
I-200-20083-426992 Certified Medical Scientists Except Epidemiologists Advertising Agencies Revhealth Llc 2020
I-200-21194-459117 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Research Institute For Fragrance Materials Inc 2021
I-200-22132-165512 Certified Medical Scientists Except Epidemiologists Research And Development In The Physical Engineering And Life Sciences Merck Sharp Dohme Llc 2022
I-200-21118-268066 Certified - Withdrawn Medical Scientists Except Epidemiologists Research And Development In The Physical Engineering And Life Sciences Merck Sharp Dohme Corp 2022
I-200-21007-999065 Certified Medical Scientists Except Epidemiologists Scientific Research And Development Services Merck Sharp Dohme Corp 2021
I-200-20344-945388 Certified Medical Scientists Except Epidemiologists Scientific Research And Development Services Merck Research Laboratories Massachusetts Llc 2021
I-200-20126-544190 Certified Medical Scientists Except Epidemiologists Scientific Research And Development Services Merck Sharp Dohme Corp 2020